During the past decade, Raffles Radiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Raffles Radiology" are "ACUTE LYMPHOBLASTIC LEUKEMIA" (1 trials), "Leukemia" (1 trials), "Ovarian Cancer" (1 trials) and "Precursor b-Cell Lymphoblastic Leukemia-Lymphoma" (1 trials). Many other conditions were trialed in "Raffles Radiology" in a lesser frequency.

Most popular intervention types in "Raffles Radiology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy + avelumab followed by avelumab + talazoparib" (1 trials), "Chemotherapy + bevacizumab followed by bevacizumab" (1 trials), "Chemotherapy followed by talazoparib maintenance" (1 trials), "Inotuzumab ozogamicin-dose level 1" (1 trials) and "inotuzumab ozogamicin-dose level 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Raffles Radiology" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Raffles Radiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Raffles Radiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Raffles Radiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".